Business impact from concentration in sales channels and end customers
First written in FY2021. 2 of 3 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024RestatedAnnual report
「Sales channels and end customers have expanded both in Japan and overseas as business activities have grown. If the financial condition of these parties deteriorates owing to worsening healthcare finances or intensifying price competition for medical devices, the Company's business activities may also be affected. Accordingly, the Company is expected to pursue balanced sales activities without excessive reliance on any particular distributor or customer.」
The Company continues to identify the risk of deterioration in the financial condition of business partners or concentration on particular parties as sales channels and end customers expand, as well as the need for balanced sales activities. - FY2022RestatedAnnual report
「Sales channels and end customers have expanded both in Japan and overseas as business activities have grown. If the financial condition of these parties deteriorates owing to worsening healthcare finances or intensifying price competition for medical devices, the Company's business activities may also be affected. Accordingly, the Company is expected to pursue balanced sales activities without excessive reliance on any particular distributor or customer.」
The Company continues to identify the risk of deterioration in the financial condition of business partners or concentration on particular parties as sales channels and end customers expand, as well as the need for balanced sales activities. - FY2021First statedAnnual report
「As described above, sales channels and end customers have expanded both in Japan and overseas as business activities have grown. If the financial condition of these parties deteriorates owing to worsening healthcare finances or intensifying price competition for medical devices, the Company's business activities may also be affected. Accordingly, the Company is expected to pursue balanced sales activities without excessive reliance on any particular distributor or customer.」
The Company has, for the first time, separately identified the risk that deterioration in the financial condition of business partners or concentration on particular parties could affect the business as sales channels and end customers expand to include medical wholesalers, medical device manufacturers, testing institutions and overseas customers.